Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OxLith short-term effects of lithium in mood instability
2014-002699-98Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lithium carbonate in bipolar disorder (BD) (2 arms), sponsored by University of Oxford. Primary endpoints: Between-group comparison of mood symptoms over the randomised period, Weekly depressive symptoms and 2 more. Started Jul 2015; status: completed.
02
Drugs
lithium carbonate
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2014-002699-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002699-98.